(Note: For PDF File Swipe To The End Of Article)
Introduction
Gout is a type of inflammatory arthritis that develops when uric acid accumulates in the body and forms microscopic crystals in and around joints. These crystals can trigger sudden, intense inflammation, causing severe pain, swelling, redness, warmth, and tenderness. An attack may begin unexpectedly, often during the night, and can make even the lightest touch against the affected joint extremely painful.
Gout most commonly affects the joint at the base of the big toe, but it can also involve the ankles, knees, wrists, fingers, elbows, and other joints. Although gout is frequently associated with the big toe, it is not limited to that location. Some people experience attacks in several joints, particularly when the condition has been present for many years.
The disease is associated with elevated uric acid levels, a condition known as hyperuricemia. However, having a high uric acid level does not automatically mean that a person has gout. Many people with hyperuricemia never develop crystal deposits or symptoms. Gout occurs when monosodium urate crystals accumulate in tissues and provoke an inflammatory response.
Gout can affect people of different ages, although it is more common in adults and becomes increasingly prevalent with age. Risk factors include genetics, impaired kidney function, obesity, certain medications, alcohol consumption, and dietary patterns that increase uric acid production or reduce its elimination.
Without appropriate treatment, gout can become a chronic condition. Repeated attacks may damage joints, and crystal deposits can form hard lumps beneath the skin called tophi. Gout is also associated with kidney stones and often occurs alongside high blood pressure, diabetes, cardiovascular disease, and chronic kidney disease.
The good news is that gout is highly manageable. Effective treatments can relieve acute attacks, reduce uric acid levels, dissolve existing crystals over time, and prevent future episodes. A combination of appropriate medication, lifestyle adjustments, and long-term monitoring can significantly improve a person's quality of life.
This comprehensive article explains gout in detail, including its definition, causes, risk factors, symptoms, stages, diagnosis, treatment, complications, dietary recommendations, prevention, and frequently asked questions.
1. What Is Gout?
Gout is an inflammatory disease caused by the deposition of monosodium urate crystals in joints and other tissues.
These crystals develop when uric acid concentrations remain high enough for urate to crystallize under the conditions present in the body. The crystals may accumulate silently for months or years before triggering an acute attack.
During an attack, the immune system recognizes the crystals and activates inflammatory pathways. White blood cells, particularly neutrophils, enter the affected tissue and release inflammatory substances. This produces the characteristic pain, swelling, warmth, and redness of gout.
Gout is one of the most common forms of inflammatory arthritis.
Unlike osteoarthritis, which primarily involves progressive changes in joint cartilage and surrounding structures, gout attacks are driven by crystal-induced inflammation. Unlike rheumatoid arthritis, which is an autoimmune inflammatory disease, gout results from the deposition of urate crystals.
However, a person can have more than one type of arthritis at the same time.
Gout can affect a single joint or multiple joints. An acute attack may resolve over several days or one to two weeks, even without treatment, but the disappearance of symptoms does not mean the crystals have been eliminated.
If uric acid remains above the level needed for crystal formation, further attacks may occur.
Important facts about gout
- Gout is caused by monosodium urate crystal deposition.
- Elevated uric acid is an important risk factor, but it does not always cause symptoms.
- The big toe is a common site of the first attack.
- Gout can affect many other joints.
- Acute attacks can be extremely painful.
- Repeated attacks can cause permanent joint damage.
- Long-term urate-lowering treatment can prevent attacks and dissolve crystal deposits.
- Gout is treatable, and many patients can achieve sustained control.
2. Understanding Uric Acid
To understand gout, it is necessary to understand uric acid and how the body produces and removes it.
Uric acid is a waste product formed when the body breaks down substances called purines.
Purines are naturally present in human cells and in many foods. They are important components of DNA, RNA, and other biological molecules.
When purines are broken down, they are eventually converted into uric acid through biochemical reactions involving the enzyme xanthine oxidase.
The body then removes uric acid primarily through the kidneys, with a smaller proportion eliminated through the intestines.
How is uric acid produced?
Uric acid comes from two main sources:
- Purines produced during the normal breakdown and recycling of the body's own cells.
- Purines obtained from foods and beverages.
The body produces uric acid continuously, even when a person does not consume purine-rich foods.
Consequently, gout is not simply a disease caused by eating too much meat. Genetics, kidney function, medication use, metabolic factors, and other influences are often equally or more important.
How is uric acid eliminated?
The kidneys filter blood and regulate the amount of urate returned to the bloodstream versus eliminated in urine.
Several transport proteins in the kidneys influence urate handling.
If the kidneys eliminate insufficient urate, blood urate levels may rise. Some people also produce more uric acid than their bodies can effectively eliminate.
Intestinal elimination contributes to overall urate balance as well.
What happens when uric acid becomes too high?
When urate concentrations remain elevated, monosodium urate crystals can form and accumulate in tissues.
The likelihood of crystallization depends on several factors, including temperature, local tissue conditions, and the concentration of urate in the surrounding fluid.
The big toe and other peripheral joints may be particularly vulnerable because cooler temperatures can favor crystal formation.
Once crystals are present, they can remain in tissues and trigger inflammatory attacks.
3. What Is Hyperuricemia?
Hyperuricemia means that the concentration of urate in the blood is elevated.
Many laboratories use approximate upper reference limits around 6–7 mg/dL, but the reference interval varies according to the laboratory and individual circumstances.
The physical chemistry of urate is important: under typical physiological conditions, the saturation threshold for monosodium urate is approximately 6.8 mg/dL.
When concentrations remain above this level, crystal formation becomes more likely, although the relationship is not immediate or identical in every person.
Does everyone with hyperuricemia develop gout?
No.
Many people have elevated uric acid without ever experiencing gout.
This is called asymptomatic hyperuricemia.
Whether crystals form and cause symptoms depends on factors such as the duration of urate elevation, genetics, joint conditions, kidney function, and other individual characteristics.
For this reason, doctors do not automatically prescribe urate-lowering medication to every person with a high uric acid level.
Treatment decisions depend on whether gout is present, whether complications exist, and the person's overall medical situation.
Can gout occur when uric acid is normal?
Yes.
During an acute gout attack, the measured serum urate level can temporarily fall into the laboratory's normal range.
Inflammation and changes in urate distribution and elimination can affect the result.
Therefore, a normal uric acid measurement during an attack does not exclude gout.
If clinical suspicion remains high, the level may be repeated after the attack has settled.
The diagnosis should be based on the overall clinical picture and, when needed, crystal analysis rather than a single uric acid measurement.
4. What Causes Gout?
Gout develops when urate accumulates and monosodium urate crystals deposit in tissues.
The underlying problem generally involves one or both of the following:
- Excessive production of uric acid.
- Insufficient elimination of uric acid.
In many patients, reduced elimination is the more important mechanism.
A. Reduced kidney elimination
The kidneys play a major role in regulating urate levels.
When kidney function is impaired, urate may accumulate in the blood.
Even people with relatively preserved kidney function can have inherited differences in the way their kidneys transport urate.
B. Increased uric acid production
Some individuals produce more uric acid because of increased purine breakdown or inherited metabolic differences.
Certain blood disorders and treatments that cause rapid cell breakdown can substantially increase uric acid production.
C. Genetic factors
Genetics influence urate production, kidney transport, and the likelihood of developing gout.
A person with close relatives who have gout may have a higher risk of developing the disease.
Genetic susceptibility can interact with dietary patterns, body weight, medications, and kidney function.
D. Dietary factors
Foods rich in purines can increase uric acid production.
Examples include organ meats, certain red meats, and some seafood.
However, dietary intake is only one part of the picture. A person may develop gout despite eating a balanced diet because of genetic susceptibility or impaired urate elimination.
E. Alcohol consumption
Alcohol can increase gout risk through several mechanisms.
It may increase urate production, reduce urate elimination, and contribute to metabolic changes that favor hyperuricemia.
Beer contains alcohol and purine-related compounds, while spirits can also increase risk. Wine may be associated with a different risk profile in some studies, but it is not risk-free for everyone.
Alcohol may trigger acute attacks in susceptible individuals.
F. Sugary drinks and fructose
Beverages containing substantial amounts of added sugar, particularly fructose, can increase uric acid production.
Regular consumption of sugar-sweetened soft drinks and some energy drinks is associated with an increased risk of gout.
Whole fruit is generally a different nutritional exposure from concentrated sugary beverages because it contains fiber, water, and other nutrients.
G. Certain medications
Some medications can increase uric acid levels.
Examples include certain diuretics, such as hydrochlorothiazide and furosemide, and low-dose aspirin.
Other medications may influence urate handling in different ways.
Patients should not stop prescribed medication without medical advice. A clinician can review whether an alternative is suitable.
H. Obesity and metabolic disorders
Excess body weight, insulin resistance, high blood pressure, abnormal blood lipids, and type 2 diabetes are associated with gout.
These conditions may affect urate production and elimination and often occur together.
I. Rapid changes in uric acid levels
Changes in urate levels can trigger attacks in susceptible people.
For example, starting urate-lowering therapy can initially increase the likelihood of an attack as existing crystals begin to destabilize or dissolve.
This is one reason preventive anti-inflammatory treatment is often recommended when urate-lowering medication is initiated.
5. Risk Factors for Developing Gout
Several factors can increase the likelihood of developing gout.
A. Age
Gout becomes more common with increasing age.
The cumulative effects of genetics, kidney function, medication exposure, and metabolic changes may contribute to this pattern.
B. Sex
Gout is more common in men than in women during much of adulthood.
Estrogen influences urate handling, which partly explains why gout becomes more common in women after menopause.
However, gout can occur in women before menopause and in younger adults.
C. Family history
Having close relatives with gout increases the likelihood of developing the condition.
This reflects the role of inherited urate metabolism and kidney transport.
D. Chronic kidney disease
Reduced kidney function can impair urate elimination.
People with chronic kidney disease may also have more complex medication choices, making medical supervision particularly important.
E. Obesity
Obesity is associated with insulin resistance and changes in urate metabolism.
Excess body weight may also contribute to inflammation and joint stress.
F. Hypertension
High blood pressure frequently occurs alongside gout.
Some blood pressure medications can raise uric acid, while hypertension itself and associated kidney changes may contribute to urate imbalance.
G. Diabetes and metabolic syndrome
Insulin resistance can influence kidney urate handling.
People with type 2 diabetes and other metabolic risk factors have an increased likelihood of hyperuricemia and gout.
H. Diet
Frequent consumption of organ meats, some seafood, large quantities of red meat, and sugar-sweetened beverages may increase risk in susceptible people.
I. Alcohol
Alcohol consumption, particularly heavy or episodic excessive consumption, can increase gout risk and trigger attacks.
J. Certain treatments and medical conditions
Cancer treatment that rapidly breaks down cells, some blood disorders, and medications affecting urate elimination can increase uric acid levels.
A clinician should consider these factors when evaluating a patient with sudden or substantial hyperuricemia.
6. Signs and Symptoms of Gout
The symptoms of gout can vary depending on the stage of the disease.
The classic presentation is a sudden attack of severe pain, swelling, redness, and warmth in one joint.
A. Sudden joint pain
A gout attack often begins abruptly.
Pain may become severe within several hours, sometimes waking the person from sleep.
Even light pressure from clothing or bedsheets may be painful.
B. Swelling
The affected joint may become visibly swollen because of inflammation and fluid accumulation.
The surrounding tissue may also appear puffy.
C. Redness
The skin over the joint may become red or reddish-purple, depending on skin tone and the severity of inflammation.
D. Warmth
The joint may feel warm to the touch because inflammatory processes increase local blood flow.
E. Tenderness
The affected area may be extremely sensitive.
Walking, standing, bending the joint, or touching the skin may produce significant pain.
F. Restricted movement
Swelling and pain can limit normal joint movement.
A person with an attack affecting the foot may struggle to walk or bear weight.
G. Recurrent attacks
Gout attacks may resolve and then return weeks, months, or years later.
Without long-term control of urate levels, attacks may become more frequent and involve additional joints.
H. Tophi
In longstanding gout, hard deposits of urate crystals may form beneath the skin.
These deposits are called tophi.
They may appear around the fingers, elbows, toes, ears, or other tissues.
Tophi can cause swelling, deformity, reduced joint movement, and sometimes skin breakdown.
7. Gout in the Big Toe: Podagra
Podagra is the term used for gout affecting the first metatarsophalangeal joint, located at the base of the big toe.
This is the classic site of an acute gout attack.
Why is the big toe commonly affected?
Several factors may contribute.
The big toe is a peripheral joint where temperatures may be relatively low, favoring urate crystal formation.
It also experiences substantial mechanical stress during walking and standing.
Local joint conditions may help create an environment in which crystals accumulate and trigger inflammation.
What does podagra feel like?
A typical episode may involve:
- Sudden, intense pain at the base of the big toe.
- Swelling around the joint.
- Redness and warmth.
- Extreme tenderness.
- Difficulty walking.
- Pain from light contact.
The symptoms may peak within approximately 12–24 hours.
Is every painful big toe caused by gout?
No.
Other possible causes include joint infection, injury, osteoarthritis, pseudogout, and inflammatory arthritis.
A first episode of a red, hot, swollen joint should be assessed by a healthcare professional, particularly when fever or systemic illness is present.
A joint infection can be dangerous and may resemble gout.
8. Other Joints Affected by Gout
Although the big toe is common, gout can affect many joints.
A. Ankles
Ankle gout may cause severe pain during walking and difficulty bearing weight.
Swelling can extend into the surrounding foot.
B. Knees
Gout affecting the knee may produce marked swelling, warmth, stiffness, and restricted movement.
A swollen knee may also result from infection or another inflammatory disorder, so diagnosis may require joint-fluid testing.
C. Wrists and fingers
Gout can affect the small joints of the hands and wrists.
This pattern becomes more likely in longstanding disease or when several joints are involved.
D. Elbows
Urate crystals may accumulate around the elbow, including near the olecranon bursa.
Tophi can develop in this region and may resemble other lumps or inflammatory conditions.
E. Multiple joints
Advanced or longstanding gout can involve several joints at once.
Polyarticular gout may be more common in older adults and in people with longstanding hyperuricemia or certain medical conditions.
9. The Four Stages of Gout
Gout is commonly described in four clinical stages.
Stage 1: Asymptomatic hyperuricemia
During this stage, uric acid levels are elevated, but the person has not experienced a gout attack or developed recognized symptoms caused by urate crystals.
Some individuals remain asymptomatic throughout life.
Others eventually develop crystal deposition and gout.
Not every person with asymptomatic hyperuricemia needs medication. Treatment depends on the clinical context and the presence of other indications.
Stage 2: Acute gout attack
The first symptomatic stage involves an acute inflammatory episode.
The affected joint becomes painful, swollen, warm, and tender.
The attack may last several days or longer, particularly without treatment.
Prompt anti-inflammatory treatment can reduce symptoms and shorten the episode.
Stage 3: Intercritical gout
Intercritical gout refers to the period between attacks.
The person may feel completely well, and the joint may appear normal.
However, urate crystals can remain in the tissues.
Without adequate urate control, another attack may occur.
This stage is important because patients may mistakenly believe the disease has disappeared once the pain resolves.
Stage 4: Chronic tophaceous gout
In longstanding uncontrolled gout, crystal deposits may accumulate in joints and soft tissues.
Tophi can become visible or palpable, and joint damage may develop.
Chronic inflammation may produce persistent pain, stiffness, and reduced mobility.
Effective urate-lowering therapy can reduce crystal burden and may shrink or eliminate tophi over time.
10. What Happens Inside a Joint During a Gout Attack?
A gout attack is an inflammatory reaction triggered by monosodium urate crystals.
When crystals accumulate in a joint, immune cells can recognize them and activate inflammatory signaling pathways.
One important pathway involves the NLRP3 inflammasome, a protein complex within certain immune cells.
Activation of this pathway promotes the release of interleukin-1 beta, a powerful inflammatory mediator.
This signal recruits neutrophils and other immune cells to the affected joint.
The resulting inflammatory response produces:
- Severe pain.
- Redness.
- Warmth.
- Swelling.
- Increased sensitivity.
- Reduced joint movement.
The crystals themselves may be present for a long time without causing symptoms. An attack occurs when the local immune response becomes activated.
This explains why two people with similar uric acid levels can have very different clinical experiences.
11. How Is Gout Diagnosed?
Gout is diagnosed using a combination of medical history, physical examination, laboratory tests, and, when needed, imaging or joint-fluid analysis.
No single blood test can reliably confirm every case.
A. Medical history
The clinician may ask about:
- The location and timing of joint pain.
- Whether symptoms began suddenly.
- Previous similar attacks.
- Family history of gout.
- Kidney disease.
- Medication use.
- Alcohol consumption.
- Dietary patterns.
- Previous kidney stones.
- Other medical conditions.
Sudden severe pain in the big toe, especially with a history of similar attacks, may strongly suggest gout.
However, symptoms alone may not be sufficient to distinguish gout from infection or other joint diseases.
B. Physical examination
The clinician examines the affected joint for swelling, redness, warmth, tenderness, and restricted movement.
The presence of tophi may support longstanding gout.
However, an examination cannot always distinguish gout from a joint infection.
C. Serum uric acid test
A blood test measures serum urate concentration.
An elevated result supports the possibility of gout in the appropriate clinical setting.
However, hyperuricemia alone does not establish the diagnosis.
Likewise, a normal result during an acute attack does not exclude gout.
If the initial result is normal but gout remains likely, the test may be repeated after the attack has settled.
D. Joint aspiration
Joint aspiration involves removing a small sample of fluid from the affected joint using a needle.
The fluid can be examined under a polarized light microscope to identify crystals.
Monosodium urate crystals are typically needle-shaped and show strong negative birefringence under polarized light.
Finding these crystals in an appropriate clinical setting provides strong evidence for gout.
Joint fluid can also be sent for cell count, Gram stain, and culture when infection is suspected.
This is important because gout and septic arthritis can occur together.
E. Imaging
Imaging can help in selected cases.
Ultrasound may identify urate deposits or a characteristic double-contour sign on the surface of cartilage.
Dual-energy computed tomography can identify urate deposits in some patients.
Plain X-rays may show characteristic erosions in longstanding gout, although early gout can have normal X-rays.
Imaging is especially useful when joint aspiration is not feasible or the diagnosis remains uncertain.
12. Blood Tests Used in the Evaluation of Gout
Several laboratory tests may be requested depending on the patient's symptoms and medical history.
A. Serum urate
This test measures the amount of urate in the blood.
It is useful for assessing hyperuricemia and monitoring the response to urate-lowering treatment.
B. Kidney function tests
Serum creatinine and estimated glomerular filtration rate help assess kidney function.
This information is important because impaired kidney function can contribute to hyperuricemia and influence medication selection.
C. Complete blood count
A complete blood count can help assess systemic inflammation, anemia, and other conditions.
An elevated white blood cell count may occur during a gout attack, but it can also occur in infection.
D. Inflammatory markers
C-reactive protein and erythrocyte sedimentation rate may increase during acute gout.
However, these markers are nonspecific and cannot reliably distinguish gout from septic arthritis.
E. Liver function tests
Liver tests may be checked before or during treatment with certain medications, depending on the drug and clinical circumstances.
F. Additional tests
Other investigations may be appropriate when the clinician suspects infection, another inflammatory arthritis, metabolic disease, or a secondary cause of hyperuricemia.
13. Conditions That Can Be Mistaken for Gout
Several disorders can cause acute joint pain and swelling.
A. Septic arthritis
Septic arthritis is a joint infection caused by bacteria or other microorganisms.
It may produce severe pain, swelling, warmth, fever, and restricted movement.
Because joint infection can rapidly damage cartilage and cause systemic illness, it is a medical emergency.
A hot, swollen joint with fever or significant illness requires urgent assessment.
Even without fever, infection cannot always be excluded by symptoms alone.
B. Pseudogout
Pseudogout is commonly associated with calcium pyrophosphate crystal deposition.
It can cause sudden joint inflammation, particularly in the knees and wrists.
The crystals differ from those of gout and have different characteristics under polarized light microscopy.
C. Septic bursitis
Infection of a bursa near a joint can cause localized swelling, redness, and pain.
This can resemble gout, particularly around the elbow or knee.
D. Osteoarthritis
Osteoarthritis causes pain and stiffness related to structural changes in the joint.
It generally develops gradually, although an osteoarthritic joint can also experience sudden inflammation.
E. Rheumatoid arthritis
Rheumatoid arthritis is an autoimmune inflammatory disease that often affects multiple joints.
Its typical pattern differs from gout, but overlap can occur.
F. Injury
Fractures, sprains, ligament injuries, and soft-tissue damage can produce swelling and pain.
An injury may also trigger a gout attack in a susceptible person.
Correct diagnosis is essential because the treatments for these conditions are not interchangeable.
14. Treatment of an Acute Gout Attack
The immediate goal of treatment is to control inflammation and relieve pain.
Acute treatment does not, by itself, eliminate all urate crystals from the body.
Common treatment options include nonsteroidal anti-inflammatory drugs, colchicine, and corticosteroids.
The appropriate choice depends on kidney function, gastrointestinal risk, cardiovascular disease, diabetes, medication interactions, pregnancy status, and other factors.
A. Nonsteroidal anti-inflammatory drugs
Nonsteroidal anti-inflammatory drugs, or NSAIDs, reduce inflammation and pain.
Examples include naproxen, indomethacin, and other medicines in this class.
They are commonly used for acute gout when appropriate.
However, NSAIDs may be unsuitable for people with certain kidney disorders, peptic ulcers, gastrointestinal bleeding risk, heart failure, or some cardiovascular conditions.
They can also interact with other medicines.
A healthcare professional should help select the safest option.
B. Colchicine
Colchicine is an anti-inflammatory medicine that interferes with processes involved in inflammatory cell activity.
It is particularly effective when started early in an acute gout attack.
Modern low-dose regimens are generally preferred over older high-dose approaches because high doses can cause significant gastrointestinal toxicity without providing additional benefit.
Common adverse effects include diarrhea, nausea, abdominal pain, and vomiting.
Colchicine can interact dangerously with certain medicines, particularly some drugs that affect CYP3A4 or P-glycoprotein. These interactions can be especially important in people with kidney or liver impairment.
The dose must follow the prescribed regimen.
C. Corticosteroids
Corticosteroids reduce inflammation and may be given orally, by injection into a joint, or through other routes in selected circumstances.
Examples include prednisolone and prednisone.
They can be useful when NSAIDs or colchicine are unsuitable.
However, corticosteroids can raise blood glucose and may affect blood pressure, mood, sleep, and infection risk.
A joint injection should not be performed without considering the possibility of joint infection.
D. Ice and rest
Resting the affected joint and applying a wrapped cold pack may help relieve discomfort.
Ice should not be placed directly against the skin, and prolonged exposure should be avoided.
Cold therapy is supportive treatment rather than a replacement for appropriate anti-inflammatory medication when needed.
E. Hydration
Maintaining adequate fluid intake supports general health and kidney function.
However, drinking excessive amounts of water does not rapidly dissolve an acute crystal deposit or replace prescribed treatment.
Fluid intake should be individualized for people with heart failure, advanced kidney disease, or medical fluid restrictions.
F. When to seek medical attention
Prompt assessment is important for a first attack, severe symptoms, an uncertain diagnosis, or an attack accompanied by fever or systemic illness.
Urgent evaluation is particularly important when septic arthritis is possible.
15. Long-Term Treatment: Lowering Uric Acid
Acute treatment reduces inflammation, but long-term gout management often requires lowering urate levels.
The purpose of urate-lowering therapy is to keep serum urate below the concentration at which crystals are likely to form.
Over time, maintaining a sufficiently low urate level allows existing crystals to dissolve.
This can reduce the frequency of attacks, shrink tophi, and help prevent further joint damage.
Who may need urate-lowering therapy?
Long-term treatment is commonly recommended for people with:
- Frequent gout attacks.
- One or more tophi.
- Gout-related joint damage.
- Certain cases of gout associated with kidney stones.
- Other selected clinical circumstances that increase the expected benefit of treatment.
The decision should be individualized.
A single uncomplicated attack does not automatically mean that every patient must begin lifelong medication, although treatment may still be appropriate depending on the clinical context.
The treat-to-target approach
A treat-to-target strategy involves adjusting treatment according to repeated serum urate measurements.
For many patients, the usual target is a serum urate concentration below 6 mg/dL.
A lower target, often below 5 mg/dL, may be considered in selected people with severe gout or substantial tophi, depending on the clinical guideline and specialist assessment.
The aim is not simply to bring the result into the laboratory's normal range. The goal is to maintain a level low enough to support crystal dissolution.
Why does treatment take time?
Existing urate deposits do not disappear immediately.
Even after blood urate levels fall, crystals may remain in joints and tissues for months or longer.
With sustained treatment, these deposits gradually dissolve.
Some patients experience additional attacks during the early months of urate-lowering therapy. This does not necessarily mean that the treatment is failing.
Preventive anti-inflammatory medication can reduce this risk.
16. Allopurinol: A Common First-Line Treatment
Allopurinol is one of the most widely used medicines for long-term urate lowering.
It inhibits xanthine oxidase, the enzyme involved in converting purine breakdown products into uric acid.
By reducing uric acid production, allopurinol helps lower serum urate and gradually dissolve crystal deposits.
How is allopurinol used?
Treatment usually begins at a low dose, which is gradually increased according to serum urate results, tolerability, kidney function, and clinical needs.
Starting with a low dose can reduce the risk of certain adverse effects and may help minimize early gout flares.
The dose required to reach the urate target varies between patients.
Some people require a dose increase even when they have kidney disease, but this should be done carefully under medical supervision rather than using a fixed dose without monitoring.
Common side effects
Possible side effects include:
- Nausea.
- Gastrointestinal discomfort.
- Skin rash.
- Changes in liver tests.
- Other less common adverse effects.
A new rash during allopurinol treatment should be taken seriously, particularly if accompanied by fever, facial swelling, blistering, mouth sores, or feeling unwell.
Allopurinol can rarely cause a severe hypersensitivity reaction involving the skin and internal organs. Such symptoms require urgent medical evaluation.
Genetic considerations
The HLA-B*58:01 genetic variant is associated with an increased risk of severe allopurinol hypersensitivity.
Testing may be recommended before treatment in certain populations with a higher prevalence of this variant, according to clinical guidance and individual risk.
Does allopurinol cure gout?
Allopurinol does not permanently correct every underlying predisposition to hyperuricemia.
However, when taken consistently and adjusted to the appropriate urate target, it can control gout very effectively.
Many patients require long-term treatment to prevent crystal reaccumulation and recurrent attacks.
.jpeg)
